Riskpilot← Back to searchSign inGet full accessØYELEGENE I MOSS AS
ASActiveOrg 928447413Ekholtveien 114, 1526 MossMedical specialists activities · NACE 8622Est. 20216 employees
Revenue 2025
NOK 4M
+8% vs 2024
EBITDA margin
0.5%
-20% vs 2024
Equity ratio
5.4%
Financial strength
Net profit 2025
NOK 0
6 employees
| Revenue | NOK 4M | +8% |
| EBITDA | NOK 21K | -20% |
| Net profit | NOK 0 | — |
| Total assets | NOK 452K | +0% |
| Equity | NOK 24K | +0% |
| Employees | 6 | — |
Legal name
ØYELEGENE I MOSS AS
Org number
928447413
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
28. desember 2021
Share capital
NOK 30 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap. Daglig leder og styrets leder i fellesskap.
Company purpose
Å eie og drifte øyelegeklinikk og det som hører med slik virksomhet.
Address
Ekholtveien 114, 1526 Moss
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 | 2 679 | 3 582 | 3 684 | 3 973 |
| Staff expenses | −0 | −2 007 | −2 129 | −2 175 | −2 251 |
| EBITDA | 0 | 6 | 20 | 26 | 21 |
| Depreciation & amort. | −0 | −6 | −20 | −26 | −21 |
| EBIT | 0 | 0 | 0 | −0 | 0 |
| Net financials | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | −0 | 0 | 0 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | 0 | 0 | 0 | 0 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 34 | 493 | 603 | 451 | 452 |
| Equity | 24 | 24 | 24 | 24 | 24 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 10 | 469 | 578 | 426 | 428 |
| Total debt | 10 | 469 | 578 | 426 | 428 |
EBITDA margin
0.5%
This company
15.8%
Market median
-97% vs market
20212025
Equity ratio
5.4%
This company
38.2%
Market median
-86% vs market
20212025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20212025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20212025
Asset turnover
8.79×
This company
1.12×
Market median
+685% vs market
20212025
Debt / equity
17.50×
This company
0.62×
Market median
-2723% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-11-23 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LH Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2022 | |
| Individual | 25% | 25% | 2022 | |
| Company | 25% | 25% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Øyelege Lh Berger As
ØYELEGENE I MOSS AS Board members of ØYELEGENE I MOSS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Haakon Weldingh Berger | Chief Executive Officer | 0 companies |
| Knut Lasse Vadla | Board of Directors | 0 companies |
| Ingeborg Lund Grønning | Chairman | 0 companies |